相关实验视频
Updated: Jun 6, 2025

05:44
Formation of Dispersible Taohong Siwu Tablets
Published on: February 3, 2023
1.5K
薄膜涂层和可片的药物等价性:使用粉碎可片进行比较溶解研究
Suck-Yong Park1,2, Sung-Up Choi1
1Department of Pharmaceutical Engineering, Cheongju University, Cheongju 28503, Republic of Korea.
Pharmaceuticals (Basel, Switzerland)
|November 27, 2024
概括
这项研究开发了一种相丁薄膜涂层片 (FT),相当于可片 (CT). 在粉碎CTs上进行溶解测试证实了新的famotidine抗酸配方的药物等价性.
科学领域:
- 制药科学 制药科学
- 药物开发 药物开发
- 分析化学 分析化学
背景情况:
- 法莫蒂丁是胃肠道疾病的组胺H2受体对抗剂.
- 可用的配方包括膜片,可片,口服悬浮剂和注射剂.
- 药物等价性要求在仿制药开发中具有类似的溶解特征.
研究的目的:
- 开发和评估一种 famotidine 薄膜涂层片 (FT).
- 确保与市场上销售的可片 (CT) 的药物等价性.
- 为可配方建立适当的溶解测试方法.
主要方法:
- 开发了一种含有 famotidine,氧化和碳酸的薄膜片 (FT).
- 使用粉碎可片 (PCT) 作为溶解测试的参考产品.
- 使用法 (50rpm) 和紫外线分析,计算相似性 (f2) 和差异 (f1) 因素.
主要成果:
- 发现薄膜片 (FT) 的溶解概况与粉碎可片 (PCT) 类似.
- 酸中和能力测试证实了FT和CT之间的抗酸相当性.
- 该研究验证了粉碎的可片用于溶解测试的使用.
结论:
- 开发的薄膜片 (FT) 在药学上相当于市场上市的可片 (CT).
- 粉碎可片 (PCT) 是通用可抗酸药的溶解测试的合适参考.
- 这种方法促进了通用胃肠道药物的开发.
相关概念视频
Factors Influencing Drug Absorption: Pharmaceutical Parameters
121
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
121
Factors Affecting Dissolution: Particle Size and Effective Surface Area
729
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
729
Bioequivalence: Overview
926
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
926
Factors Influencing Drug Absorption: Drug Dissolution
422
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
422
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
287
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
287
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
177
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
177

